DUSP22 -rearranged ALK-negative anaplastic large cell lymphoma is a pathogenetically distinct disease but can have variable clinical outcome

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 108; no. 6; pp. 1463 - 1467
Main Authors Savage, Kerry J, Slack, Graham W
Format Journal Article
LanguageEnglish
Published Italy Fondazione Ferrata Storti 01.06.2023
Ferrata Storti Foundation
Subjects
Anaplastic Lymphoma Kinase - genetics
Dual-Specificity Phosphatases - genetics
Humans
Lymphoma, Large-Cell, Anaplastic - genetics
Lymphoma, Large-Cell, Anaplastic - pathology
Mitogen-Activated Protein Kinase Phosphatases - genetics
Receptor Protein-Tyrosine Kinases
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
Disclosures
KJS has received honoraria from and acted as a consultant for BMS, Merck, Seagen, Kyowa, Novartis, Janssen and Abbvie; has participated in a steering committee for Beigene; and has sat on a Data and Safety Monitoring Committee for Regeneron. GWS has received honoraria from and acted as a consultant for Seattle Genetics.
Contributions
KJS and GWS wrote and approved the manuscript.
ISSN:0390-6078
1592-8721
DOI:10.3324/haematol.2022.282025